S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.51 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.51 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.51 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.51 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
OTCMKTS:PBSV

Pharma-Bio Serv (PBSV) Stock Forecast, Price & News

$1.03
+0.03 (+3.51%)
(As of 04:15 PM ET)
Compare
Today's Range
$0.99
$1.03
50-Day Range
$0.85
$1.08
52-Week Range
$0.68
$1.20
Volume
5,008 shs
Average Volume
5,218 shs
Market Capitalization
$23.67 million
P/E Ratio
14.71
Dividend Yield
N/A
Price Target
N/A

PBSV stock logo

About Pharma-Bio Serv (OTCMKTS:PBSV) Stock

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in the United States and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

PBSV Price History

PBSV Stock News Headlines

PBSV Boosts Margins and Expands Markets
Fox Couldn't Air my #1 A.I. Pick - Get it Here.
50-year Wall Street Insider Marc Chaikin got invited onto Fox News to talk about A.I. - Here's what he couldn't say on television. More here.
Pharma-Bio Serv Inc
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
TBPMF - Tetra Bio-Pharma Inc.
PBSV - Pharma-Bio Serv, Inc.
Bio Pharma Buffer Market Research | 2023-2030
PBSV: A Steady Performer with Upside Potential
4 Analysts Have This to Say About BridgeBio Pharma
See More Headlines
Receive PBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter.

PBSV Company Calendar

Last Earnings
9/14/2023
Today
9/27/2023
Fiscal Year End
10/31/2023

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
N/A
Current Symbol
OTCMKTS:PBSV
Employees
140
Year Founded
N/A

Profitability

Net Income
$1.01 million
Pretax Margin
10.91%

Debt

Sales & Book Value

Annual Sales
$19.40 million
Cash Flow
$0.05 per share
Book Value
$0.70 per share

Miscellaneous

Free Float
20,226,000
Market Cap
$23.67 million
Optionable
Not Optionable
Beta
0.41
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Victor Sanchez (Age 52)
    CEO, Pres & Pres of European Operations
    Comp: $298.9k
  • Mr. Pedro J. Lasanta (Age 63)
    CFO, VP of Fin. & Admin. and Sec.
    Comp: $208.6k
  • Ms. Elizabeth Plaza (Age 59)
    Founder & Sr. Strategic Consultant
  • Ms. Miriam Marrero M.B.A.
    HR Mang.













PBSV Stock - Frequently Asked Questions

How have PBSV shares performed in 2023?

Pharma-Bio Serv's stock was trading at $0.79 on January 1st, 2023. Since then, PBSV shares have increased by 30.4% and is now trading at $1.03.
View the best growth stocks for 2023 here
.

Are investors shorting Pharma-Bio Serv?

Pharma-Bio Serv saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 3,300 shares, a decline of 21.4% from the August 31st total of 4,200 shares. Based on an average trading volume of 3,800 shares, the days-to-cover ratio is currently 0.9 days.
View Pharma-Bio Serv's Short Interest
.

How were Pharma-Bio Serv's earnings last quarter?

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) released its earnings results on Thursday, September, 14th. The company reported $0.02 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.02. The firm earned $4.58 million during the quarter, compared to the consensus estimate of $5.40 million. Pharma-Bio Serv had a trailing twelve-month return on equity of 9.36% and a net margin of 8.49%.

How often does Pharma-Bio Serv pay dividends? What is the dividend yield for Pharma-Bio Serv?

Pharma-Bio Serv announced a dividend on Wednesday, March 22nd. Shareholders of record on Wednesday, March 29th will be paid a dividend of $0.075 per share on Friday, April 14th. This represents a yield of 7.75%. The ex-dividend date of this dividend is Tuesday, March 28th.
Read our dividend analysis for PBSV
.

What other stocks do shareholders of Pharma-Bio Serv own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pharma-Bio Serv investors own include Zynerba Pharmaceuticals (ZYNE), Allena Pharmaceuticals (ALNA), AstroNova (ALOT), Oracle (ORCL), AT&T (T), Yintech Investment (YIN), Aeglea BioTherapeutics (AGLE), Ampliphi Biosciences (APHB), Carnival Co. & (CCL) and Earthstone Energy (ESTE).

What is Pharma-Bio Serv's stock symbol?

Pharma-Bio Serv trades on the OTCMKTS under the ticker symbol "PBSV."

How do I buy shares of Pharma-Bio Serv?

Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pharma-Bio Serv's stock price today?

One share of PBSV stock can currently be purchased for approximately $1.03.

How much money does Pharma-Bio Serv make?

Pharma-Bio Serv (OTCMKTS:PBSV) has a market capitalization of $23.67 million and generates $19.40 million in revenue each year. The company earns $1.01 million in net income (profit) each year or $0.07 on an earnings per share basis.

How many employees does Pharma-Bio Serv have?

The company employs 140 workers across the globe.

How can I contact Pharma-Bio Serv?

Pharma-Bio Serv's mailing address is Pharma-Bio Serv Building Suite 6 Road 696, DORADO PR, 00646. The official website for the company is www.pharmabioserv.com. The company can be reached via phone at (787) 278-2709, via email at scottg@corprominence.com, or via fax at 787-796-5168.

This page (OTCMKTS:PBSV) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -